IGF1 and cancer: Systemically and in consideration of other cancer types, plausible mechanisms include the suppression of the insulin/insulin-like growth factor-1 (IGF-1) signaling cascade, effects on growth-promoting androgenic and estrogenic factors present in circulation, as well as the suppression of circulating proinflammatory cytokines [4,6,7,8].